Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,828 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
BRAF and NRAS mutations and antitumor immunity in Korean malignant melanomas and their prognostic relevance: Gene set enrichment analysis and CIBERSORT analysis.
Min KW, Choe JY, Kwon MJ, Lee HK, Kang HS, Nam ES, Cho SJ, Park HR, Min SK, Seo J, Kim YJ, Kim NY, Kim HY. Min KW, et al. Among authors: kim yj, kim hy, kim ny. Pathol Res Pract. 2019 Dec;215(12):152671. doi: 10.1016/j.prp.2019.152671. Epub 2019 Sep 27. Pathol Res Pract. 2019. PMID: 31630873 Free article.
The Clinical Utility of FDG PET-CT in Evaluation of Bone Marrow Involvement by Lymphoma.
Kim HY, Kim JS, Choi DR, Kim HS, Kwon JH, Jang GD, Kim JH, Jung JY, Song HH, Lee YK, Min SK, Hwang HS, Kim HJ, Zang DY, Kim HJ. Kim HY, et al. Among authors: kim hj, kim js, kim hs, kim jh. Cancer Res Treat. 2015 Jul;47(3):458-64. doi: 10.4143/crt.2014.091. Epub 2014 Nov 24. Cancer Res Treat. 2015. PMID: 25648095 Free PMC article.
Erratum to "BRAF and NRAS mutations and antitumor immunity in Korean malignant melanomas and their prognostic relevance: Gene set enrichment analysis and CIBERSORT analysis" [Pathol. Res. Pract. 215 (12) (2019) 152671].
Min KW, Choe JY, Kwon MJ, Lee HK, Kang HS, Nam ES, Cho SJ, Park HR, Min SK, Seo J, Kim YJ, Kim NY, Kim HY. Min KW, et al. Among authors: kim yj, kim hy, kim ny. Pathol Res Pract. 2021 Mar;219:153316. doi: 10.1016/j.prp.2020.153316. Epub 2021 Feb 19. Pathol Res Pract. 2021. PMID: 33618249 Free article. No abstract available.
Protective role of CYP1A1*2A in the development of multiple myeloma.
Kang SH, Kim TY, Kim HY, Yoon JH, Cho HI, Yoon SS, Kang DH, Suh CW, Lee JH, Lee DS. Kang SH, et al. Among authors: kim hy, kim ty. Acta Haematol. 2008;119(1):60-4. doi: 10.1159/000117572. Epub 2008 Feb 20. Acta Haematol. 2008. PMID: 18285692
Clinical features and survival outcomes in patients with multiple myeloma: analysis of web-based data from the Korean Myeloma Registry.
Kim SJ, Kim K, Kim BS, Jo DY, Kang HJ, Kim JS, Mun YC, Kim CS, Sohn SK, Eom HS, Kwak JY, Shim H, Yoon HJ, Jin JY, Min CK, Shin H, Won JH, Lee JJ, Kwon JH, Joo YD, Do YR, Kim SH, Oh S, Suh C, Lee J, Yoon SS, Kim MK, Bang SM, Ryoo HM, Kim BS, Kim H, Kim HJ, Kim YS, Park CW, Lee GW, Shin HJ, Park SK, Park JS, Kim HY, Lee DS, Lee JH; Korean Multiple Myeloma Working Party. Kim SJ, et al. Among authors: kim cs, kim bs, kim h, kim hy, kim hj, kim sh, kim js, kim ys, kim k, kim mk. Acta Haematol. 2009;122(4):200-10. doi: 10.1159/000253027. Epub 2009 Oct 29. Acta Haematol. 2009. PMID: 19887776
6,828 results